SML4143
DT-061
≥98% (HPLC)
Synonym(s):
DT 061, DT061, SMAP, SMAP1, NZ-8-061, N-[(1R,2R,3S)-2-Hydroxy-3-(10H-phenoxazin-10-yl)cyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide
Select a Size
About This Item
Quality Level
Assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
SMILES string
O[C@H]1[C@@H](CCC[C@@H]1N2C3=C(OC4=C2C=CC=C4)C=CC=C3)NS(C5=CC=C(C=C5)OC(F)(F)F)(=O)=O
Biochem/physiol Actions
DT-061 is an orally active, small molecule activator of PP2A (NZ-8-061; SMAP1) that drives protein phosphatase 2 (PP2, PP2A) conformational changes by targeting the scaffold subunit Aα. DT-061 induces apoptotic death in cancer cultures (A549, H441, H358 IC50 ≤10 uM by MTT assay) and in mice in vivo (15 mg/kg with KRASLA2 transgenic model or 5 mg/kg with PDX tumor fragments or H358 xenograft model; via b.i.d. oral gavage) with little adverse effects to the animals.
Disclaimer
Regulatory Information
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service